Overview

Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI)

Status:
Withdrawn
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
A three-group parallel randomized controlled trial to evaluate the efficacy of virtual reality analgesia (VRA) to decrease patient procedural pain and anxiety in the Adult patients undergoing Spinal Injections (SI).
Phase:
Phase 2
Details
Lead Sponsor:
Albert Einstein College of Medicine
Albert Einstein College of Medicine, Inc.
Treatments:
Bupivacaine
Lidocaine